Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMing Yang Smart Regulatory News (MYSE)

Share Price Information for Ming Yang Smart (MYSE)

Share Price is delayed by 15 minutes
Get Live Data
11.70    0.00 (0.00%)
Bid:
10.20
Ask:
10.50
Spread: 0.30 (2.941%)
Market Cap: $5.29b
MYSE Live PriceLast checked at - London Stock Exchange

Intraday Ming Yang Smart Share Chart

  • This share is an international stock.

Pre-Stabilisation Notice

8 Jul 2022 07:00

RNS Number : 7757R
UBS AG London Branch
08 July 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

MING YANG SMART ENERGY GROUP LIMITED

Pre-Stabilisation Notice

8 July 2022

UBS AG London Branch (contact: Francois-Olivier Mercier, Syndicate Desk, telephone: +44 207 567 8000) hereby gives notice that the entity undertaking stabilisation (the "Stabilising Manager" named below and its affiliates) may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 as such legislation forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. Stabilisation may not necessarily occur and it may cease at any time.

The securities:

Issuer:

MING YANG SMART ENERGY GROUP LIMITED

Securities:

Global depositary receipts (the "GDRs") each representing 5 A shares of the Company

ISIN:

US6034912005 (RegS GDRs)

Offering size:

31,280,500 GDRs (excluding the over-allotment option)

Market:

London Stock Exchange plc, Shanghai-London Stock Connect segment

Ticker:

MYSE

Description

Initial Public Offering of GDRs

Offer Price:

USD 21.00 per GDR

Stabilisation:

Stabilisation Manager (and central point within the meaning of Commission Delegated Regulation (EU) 2016/1052):

UBS AG London Branch, 5 Broadgate, London EC2M 2QS

Contact: Francois-Olivier Mercier, Syndicate Desk, telephone: +44 207 567 8000

Beginning of the Stabilisation Period:

8 July 2022

Stabilisation Period to end no later than:

5 August 2022

Trading venue where stabilisation may be undertaken:

London Stock Exchange plc, over-the-counter (OTC) and other order book venues e.g. Turquoise, BATS and Chi-X

Maximum size of Over-allotment Option:

2,380,000 GDRs

Over-allotment & Greenshoe Option:

Terms:

In connection with the offer of GDRs (the "Offer"), the Stabilising Manager, or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot GDRs or effect other transactions with a view to supporting the market price of the GDRs at a level higher than that which might otherwise prevail in the open market. However, there is no assurance that the Stabilising Manager (or persons acting on its behalf) will undertake stabilisation action and there will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions. In particular, the Stabilising Manager's ability to undertake stabilisation action depends on it being able to agree deferred settlement arrangements with one or more investors in order to allow it to over-allot GDRs. Any stabilisation action may begin on the date of adequate public disclosure of the final price of the GDRs and, if begun, may be ended at any time but must end no later than 30 calendar days thereafter (the "Stabilisation Period"). Any stabilisation action must be undertaken in accordance with applicable laws and regulations. Such stabilisation, if commenced, may be discontinued at any time without prior notice. Save as required by law or regulation, the Stabilising Manager does not intend to disclose the extent of any over-allotments made and/or stabilisation transactions concluded in relation to the Offer.

In connection with the Offer, the Stabilising Manager may, for stabilisation purposes and subject to the deferred settlement arrangements described above, over-allot up to 2,380,000 GDRs. For the purposes of allowing it to cover short positions resulting from any such over-allotments and/or from sales of GDRs effected by it during the Stabilisation Period, the Stabilising Manager will enter into over-allotment arrangements pursuant to which the Stabilising Manager may purchase or procure purchasers for up to 2,380,000 additional GDRs (the "Over-allotment GDRs") at the Offer price. The over-allotment arrangements will be exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the date of announcement of the Offer Price on the London Stock Exchange. Any Over-allotment GDRs made available pursuant to the over-allotment arrangements, including for all dividends and other distributions declared, made or paid on the GDRs, will be purchased on the same terms and conditions as the GDRs being issued or sold in the Offer and will form a single class for all purposes with the other GDRs.

Number of GDRs covered by Over-allotment Option:

2,380,000 GDRs

Duration:

The Over-allotment Option may be executed at any time during the Stabilisation Period.

 

 

 

 

Disclaimer

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete nor does it constitute or form part of any invitation or inducement to engage in investment activity, nor does it constitute an offer or invitation to buy any securities in any jurisdiction including the United States, or a recommendation in respect of buying, holding or selling any securities. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, Japan or South Africa. This announcement does not constitute or form a part of any offering or solicitation to purchase or subscribe for, or otherwise invest in, securities in the United States, Australia, Japan or South Africa. The GDRs referred to herein have not been, and will not be, registered under the United States Securities Act of 1933 (the "Securities Act"). The GDRs are being offered and sold outside the United States in "offshore transactions" within the meaning of Regulation S under the Securities Act.

 

The GDRs may not be offered or sold in the United States except pursuant to an exemption from or in a transaction not subject to the registration requirements of the Securities Act. There will be no public offering of securities in the United States.

 

This announcement is only addressed to and directed at specific addressees who: (A) if in member states of the European Economic Area (the "EEA"), are persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) ("Qualified Investors"); and (B) if in the United Kingdom, are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018, and who are: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order; or (C) are other persons to whom it may otherwise lawfully be communicated (all such persons referred to in (B) and (C) being referred to as "Relevant Persons"). This announcement must not be acted or relied on (i) in the United Kingdom, by persons who are not Relevant Persons and (ii) in any member state of the EEA by persons who are not Qualified Investors. Any investment activity to which this announcement relates (i) in the United Kingdom is available only to, and may be engaged in only with, Relevant Persons; and (ii) in any member state of the EEA is available only to, and may be engaged only with, Qualified Investors.

 

 

 

 

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFIFEIDVITIIF
Date   Source Headline
22nd May 202610:49 amRNSProgress of Asset Acquisition
20th May 202611:12 amRNSResolution of the Annual General Meeting of 2025
28th Apr 20265:14 pmRNS2026 First Quarterly Report
28th Apr 20265:04 pmRNSNotice of the 2025 AGM
28th Apr 20264:58 pmRNS2025 Annual Report
28th Apr 20264:57 pmRNS2025 Sustainability Report
27th Apr 202612:30 pmRNSIssuance of 2026 Green Sci-Tech Bonds (Tranche 1)
22nd Apr 20269:44 amRNSProgress of Asset Acquisition
31st Mar 202610:23 amRNSResolution of the First 2025 ESOP Holders‘ Meeting
27th Mar 20267:00 amRNSProgress of External Investment
23rd Mar 20267:00 amRNSProgress of Asset Acquisition
2nd Mar 20269:47 amRNSResolution of the Second EGM of 2026
23rd Feb 20268:49 amRNSProgress of Asset Acquisition
9th Feb 202610:23 amRNSNotice of the Second EGM of 2026
5th Feb 20262:59 pmRNSReply to the Inquiry from SSE
28th Jan 202610:14 amRNSAnticipated Annual Performance Increase
26th Jan 20262:11 pmRNSAbnormal Fluctuations in Stock Trading
23rd Jan 20263:53 pmRNSInquiry Letter from SSE
22nd Jan 20262:51 pmRNSAsset Acquisition Proposal
22nd Jan 20262:38 pmRNSPostponement of the Shareholders' Meeting
22nd Jan 20262:35 pmRNSTop Ten Shareholders 12 January 2026
22nd Jan 20262:32 pmRNSResumption of Trading of the Company's Stock
19th Jan 202610:24 amRNSProgress of Trading Suspension
19th Jan 202610:20 amRNSResolution of the First EGM in 2026
13th Jan 202611:00 amRNSTrading Suspension for Asset Acquisition
29th Dec 20259:40 amRNSCompletion of Non-Trading Transfer for 2025 ESOP
29th Dec 20259:40 amRNSCompletion of Non-Trading Transfer for 2025 ESOP
23rd Dec 20259:29 amRNSNotice of the First EGM in 2026
23rd Dec 20259:29 amRNSNotice of the First EGM in 2026
8th Dec 20259:02 amRNSCancellation of Repurchased Shares
1st Dec 20259:47 amRNSRegistration for the Granted Stock Option
30th Oct 20259:39 amRNS2025 Third Quarterly Report
22nd Oct 202510:46 amRNSGranting Stock Options to Incentive Recipients
20th Oct 202510:49 amRNSResolution of the Third EGM in 2025
13th Oct 20257:33 amRNSAnnouncement on Planning External Investment
25th Sep 202512:25 pmRNSEmployee Stock Ownership Plan (Draft)
25th Sep 202512:21 pmRNSStock Option Incentive Plan (Draft)
25th Sep 202512:16 pmRNSNotice of the Third EGM in 2025
9th Sep 202511:27 amRNSElection of Employee Representative Director
9th Sep 202511:07 amRNSResolution of the Second EGM in 2025
27th Aug 202510:44 amRNS2025 Interim Report
14th Aug 202510:51 amRNSNotice of the Second EGM in 2025
14th Aug 202510:42 amRNSDirector Resignations, Appointments & Mgmt Changes
14th Aug 202510:35 amRNSAbolish Supervisory Committee & Amend Articles
7th Jul 20258:51 amRNSResignation of the Vice Chairman
25th Jun 202510:49 amRNS2024 Dividend Distribution
21st May 202512:44 pmRNSResolution of the 2024 AGM
25th Apr 20255:55 pmRNS2024 Annual Report
25th Apr 20255:30 pmRNS2024 Annual Report
25th Apr 20253:35 pmRNS2025 First Quarterly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.